26/05/2017
Skip Navigation Links
Home
AboutACECR
All Products A-Z
Organization
Publications
Contact Us
 
Fields of Activity :
Research and Technology
Entrepreneurship and Job Creation
Education
Culture and Arts
 
Links:
ASPxHyperLink

ASPxHyperLink

ASPxHyperLink

ASPxHyperLink

 
 
 
 
 
Health, Biology and Medicine>Cell Therapy >
Cell therapy for Heart diseases
  • Transplantation of BM-derived CD133+ cells in patients with acute myocard infraction during PCI
  • Transplantation of BM-derived mononuclear cells in patients with acute myocard infraction during CABG

    Patients with acute myocard infraction who have inclusion criteria for our study are candidate for cell therapy.
     Patients undergo bone marrow aspiration the cell will be separated and injected to heart during PCI or CABG. These cells can increase ejection fraction of heart and decrease the size of scar and improve life quality.

The ACECR affiliate in charge:
Reproductive Biomedicine Stem Cell Biology and Technology (Royan Institute)
Inquiry
 
 
 
      
 
 
 
  
Sectors:
Petroleum Industry
Rail Transportation
Biotechnology
Power Generation
Renewable Energy
 
ASPxHyperLink
ASPxHyperLink
ASPxHyperLink
 
                     Contact Us     Privacy Statement    Terms Of Use
                            Copyright @ 2008 Academic Center for Education, Culture and Research, All Rights Reserved